Early research (Phase 1)Study completedNCT04439006
What this trial is testing
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10